ITI Life Sciences, Scotland’s publicly funded innovation group, is to invest a further £2 million in its programme to develop new drug discovery tools.
Thomas Geelhaar, Head of Chemicals R&D at Merck in Darmstadt, Germany, describes how the company scouts for technologies and interacts with universities.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.